Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KS Bioenergi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.6% 1.6% 1.6% 1.6% 1.6% 1.6% 1.6% 1.6%   Bankruptcy risk   5.2% 11.0% 4.3% 4.7% 5.9% 3.8% 10.4% 10.4%   Credit score (0-100)   44 22 46 45 38 51 24 24   Credit rating   BBB BB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 -0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   305 -44.1 370 184 103 607 0.0 0.0   EBITDA   305 -44.1 370 184 103 607 0.0 0.0   EBIT   265 -79.7 338 155 76.1 577 0.0 0.0   Pre-tax profit (PTP)   216.8 -119.1 304.1 140.9 63.0 575.7 0.0 0.0   Net earnings   197.8 -119.1 263.2 109.5 48.8 448.8 0.0 0.0   Pre-tax profit without non-rec. items   217 -119 304 141 63.0 576 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   327 294 265 238 214 246 0.0 0.0   Shareholders equity total   106 -12.8 250 360 409 857 807 807   Interest-bearing liabilities   699 746 259 306 244 28.3 0.0 0.0   Balance sheet total (assets)   877 770 663 872 788 1,050 807 807   Net Debt   699 746 259 306 244 -224 -807 -807     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   305 -44.1 370 184 103 607 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% -50.1% -44.2% 490.1% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   877 770 663 872 788 1,050 807 807   Balance sheet change%   -13.0% -12.3% -13.9% 31.6% -9.7% 33.3% -23.1% 0.0%   Added value   304.6 -44.1 369.9 184.4 105.5 606.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -63 -71 -65 -59 -53 -1 -253 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   87.1% 180.6% 91.3% 84.1% 74.0% 95.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   26.8% -9.6% 46.7% 20.2% 9.2% 63.0% 0.0% 0.0%   ROI %   28.0% -10.3% 53.8% 26.4% 11.5% 75.3% 0.0% 0.0%   ROE %   35.5% -27.2% 51.6% 35.9% 12.7% 70.9% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   12.1% -1.6% 37.8% 41.3% 51.9% 81.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   229.5% -1,691.2% 70.0% 165.9% 237.2% -37.0% 0.0% 0.0%   Gearing %   658.1% -5,816.8% 103.4% 85.0% 59.7% 3.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.4% 5.4% 6.7% 5.0% 4.8% 2.6% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.0 0.0 0.1 0.2 0.2 2.2 0.0 0.0   Current Ratio   0.7 0.6 0.9 1.2 1.5 4.1 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 252.6 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -241.2 -324.7 -29.2 121.7 185.2 604.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0